KRAS and colorectal carcinoma: Although it is not clear what mechanisms are involved in gefitinib-resistance in Colo_160224 primary cell culture; however, NDAT suppressed PI3K activation and PD-L1 accumulation to inhibit cancer growth in Colo_160224 cells and K-RAS mutant HCT116 CRC cells.